Related Experiment Video

Updated: May 1, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

21.6K

The prognostic impact of myocardial late gadolinium enhancement

Roman Panovsky1, Martin Pleva, Vera Feitova

  • 1From the *Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne's Faculty Hospital and Masaryk University, Brno, Czech Republic; †Department of Interventional Radiology, Hospital Trinec-Podlesi, Trinec, Czech Republic; ‡Department of Medical Imaging, St. Anne's Hospital, Masaryk University, Brno, Czech Republic; and §Institute of Normal and Pathological Physiology and Center of Excellence for Regulatory Role of Nitric Oxide in Civilization Diseases, Slovak Academy of Sciences, Bratislava, Slovak Republic.

Cardiology in Review
|April 5, 2014
PubMed

Insights

Late gadolinium enhancement (LGE) in cardiovascular magnetic resonance imaging helps characterize heart tissue and predict adverse outcomes. New methods for measuring diffuse myocardial fibrosis could further enhance LGE

Area of Science:

  • Cardiovascular imaging
  • Cardiac MRI
  • Tissue characterization

Background:

  • Late gadolinium enhancement (LGE) in cardiovascular magnetic resonance (CMR) allows in vivo myocardial tissue assessment.
  • LGE is crucial for characterizing ischemic and nonischemic cardiomyopathies and other cardiac conditions.
  • LGE is linked to adverse clinical outcomes and can improve risk stratification beyond traditional markers.

Purpose of the Study:

  • To highlight the prognostic impact of LGE in various cardiac disorders.
  • To emphasize the potential of new CMR methods for diffuse myocardial fibrosis measurement.
  • To explore the application of diffuse myocardial fibrosis evaluation in early-stage, large-scale diseases.

Main Methods:

  • Utilizing cardiovascular magnetic resonance with late gadolinium enhancement (LGE).
  • Developing and validating novel CMR techniques for diffuse myocardial fibrosis assessment.
  • Analyzing LGE data for prognostic implications in cardiac diseases.

Main Results:

  • LGE is frequently associated with adverse clinical outcomes in cardiac disorders.
  • Limited trials exist for some diseases, but prognostic impact of LGE is expected to grow.
  • New methods for diffuse fibrosis measurement are anticipated to enhance LGE's prognostic value.

Conclusions:

  • LGE is a valuable tool for risk stratification in cardiac conditions.
  • Further development in diffuse myocardial fibrosis measurement holds significant potential.
  • Evaluating diffuse fibrosis can aid in early disease detection, risk identification, and treatment monitoring.

More Related Videos

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease12:15

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease

Published on: February 8, 2022

4.9K
Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques06:29

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

Published on: June 11, 2019

10.4K

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K